1 |
Abol-Enein H (2008). Infection: is it a cause of bladder cancer? Scand J Urol Nephrol, 79-84.
|
2 |
Chow WH, Lindblad P, Gridley G, et al (1997). Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst, 89, 1453-7.
DOI
|
3 |
El-Mosalamy H, Salman TM, Ashmawey AM, et al (2012). Role of chronic E. coli infection in the process of bladder cancer- an experimental study. Infect Agent Cancer, 7, 19.
DOI
|
4 |
Pasin E, Josephson DY, Mitra AP, et al (2008). Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol, 10, 31-43.
|
5 |
Pelucchi C, Bosetti C, Negri E, et al (2006). Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol, 3, 327-40.
DOI
|
6 |
Radomski JL, Greenwald D, Hearn WL, et al (1978). Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer. J Urol, 120, 48-50.
DOI
|
7 |
Shakhssalim N, Hosseini SY, Basiri A, et al (2010). Prominent bladder cancer risk factors in Iran. Asian Pac J Cancer Prev, 11, 601-6.
|
8 |
Sievert KD, Amend B, Nagele U, et al (2009). Economic aspects of bladder cancer: what are the benefits and costs? World J Urol, 27, 295-300.
DOI
|
9 |
Sturgeon SR, Hartge P, Silverman DT, et al (1994). Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiol, 5, 218-25.
DOI
|
10 |
Vermeulen SH, Hanum N, Grotenhuis AJ, et al (2015). Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study. Br J Cancer, 112, 594-600.
DOI
|
11 |
Jiang X, Castelao JE, Groshen S, et al (2009). Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer, 100, 834-9.
DOI
|
12 |
Gonzalez CA, Errezola M, Izarzugaza I, et al (1991). Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer, 27, 498-500.
DOI
|
13 |
Hicks RM, Walters CL, Elsebai I, et al (1977). Demonstration of nitrosamines in human urine: preliminary observations on a possible etiology for bladder cancer in association with chronic urinary tract infections. Proc R Soc Med, 70, 413-7.
|
14 |
Jhamb M, Lin J, Ballow R, et al (2007). Urinary tract diseases and bladder cancer risk: a case-control study. Cancer Causes Control, 18, 839-45.
DOI
|
15 |
Johansson S, Wahlqvist L (1977). Tumours of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. Acta Pathologica Microbiologica Scandinavica Section A Pathol, 85, 768-74.
|
16 |
Kantor AF, Hartge P, Hoover RN, et al (1984). Urinary tract infection and risk of bladder cancer. Am J Epidemiol, 119, 6.
|
17 |
Karin M, Greten FR (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol, 5, 749-59.
DOI
|
18 |
La Vecchia C, Negri E, D’Avanzo B, et al (1991). Genital and urinary tract diseases and bladder cancer. Cancer Res, 51, 629-31.
|
19 |
Lax AJ, Thomas W (2002). How bacteria could cause cancer: one step at a time. Trends Microbiol, 10, 293-9.
DOI
|
20 |
Nesi G, Nobili S, Cai T, et al (2015). Chronic inflammation in urothelial bladder cancer. Virchows Arch, 467, 623-33.
DOI
|
21 |
Parkin DM (2008). The global burden of urinary bladder cancer. Scand J Urol Nephrol, 12-20.
|